RECENTLY ANNOUNCED: Flatiron Health’s newly launched Trusted Partners Network is a curated selection of technology and service providers with proven positive impact in oncology. This initiative helps partners expand their reach and drives greater value for community oncology. Read more from Flatiron's VP, Strategic Partnerships and Alliances, Nina Chavez https://lnkd.in/eY_63UiW
Flatiron Health’s Post
More Relevant Posts
-
In this interview, Lalan Wilfong, M.D., shares insights from the Community Oncology Alliance’s 2024 Community Oncology Conference panel session titled "Defining Value in Oncology: Executing VBC Accurately & Ethically to Account for All Stakeholders." "Whenever we go into a value-based care arrangement, we want to make sure that the true heart of that is improving patient care and making sure that all of the payment models, quality metrics, and everything else goes toward improving that patient’s outcome and quality of life during the time we're under that model," said Dr Wilfong. Check out the full video here: https://lnkd.in/emqpV3wE #JournalOfClinicalPathways #ValueBasedCare #CancerCare #Oncology #EnhancingOncologyModel #COA2024
Balancing the Benefits and Risks of Value-Based Care Arrangements
hmpgloballearningnetwork.com
To view or add a comment, sign in
-
CCF's Chief Patient Officer, Melinda Bachini, co-authored Amplifying the Patient's Voice in Oncology Early-Phase Clinical Trials: Solutions to Burdens and Barriers in the American Society of Clinical Oncology (ASCO) Education Book. Melinda contributed a unique look at the specific burdens and barriers patients face when participating in dose-finding oncology trials (DFOTs). Read it here: https://lnkd.in/ggBr7VtQ #patientvoice #patientperspective #clinicaltrials #DFOT #patientadvocacy
Amplifying the Patient's Voice in Oncology Early-Phase Clinical Trials: Solutions to Burdens and Barriers | American Society of Clinical Oncology Educational Book
ascopubs.org
To view or add a comment, sign in
-
The oncology space is no longer subject to minimal payer management. MMIT’s Jory Fleischauer discusses utilization management and the likely rise in competitive contracting coming to this therapeutic area. Read now: https://ow.ly/7X9S50Rlykx #OncologyTherapies #CancerCare #PayerManagement #Oncology
Changing Payer Management Dynamics at Play in Oncology
https://www.mmitnetwork.com
To view or add a comment, sign in
-
How are payers responding to the growth of competitive therapies in oncology? In this blog, MMIT’s Jory Fleischauer, Pharm.D. takes a look at the data on payer management approaches. Read now: https://ow.ly/gX1t50RlxVc #OncologyTherapies #CancerCare #PayerManagement #Oncology
Changing Payer Management Dynamics at Play in Oncology
https://www.mmitnetwork.com
To view or add a comment, sign in
-
Our goal at Zelta is to simplify the complex world of oncology trials. Here is good information about the trends in oncology trials starting in 2024. Thanks Walker Bradham for all that you and the development team do to support our clients to be more efficient and reduce their burden of managing clinical trials. #clinicaldatamanagement #clinicaltrials #zelta #merative
Oncology in 2024: The clinical trial trends reshaping the role of CROs
clinicaltrialsarena.com
To view or add a comment, sign in
-
MS5 | Research enthusiast | Steering committee member at TEFF-Official | Research mentor at TEFF-KMDC
Hi, I hope this message finds you well. I am writing to share an exciting proposal with you - the establishment of *The Oncology Case Discussion Forum*, an upcoming platform designed exclusively for professionals dealing with oncology patients. The Oncology Case Discussion Forum aims to provide a collaborative space where oncologists can share challenging clinical cases, engage in evidence-based discussions, and access resources to enhance patient care and professional development. Before launching the forum, we would like to gather insights and feedback from esteemed professionals like yourself. Your input will be invaluable in shaping the platform to meet the needs and expectations of the oncology community. Key Objectives of the Survey: - Assess the need and interest in a collaborative case consultation forum among oncologists. - Understand the expectations and preferences regarding the features and functionality of the forum. - Identify potential challenges and concerns that need to be addressed before launching the platform. We invite you to participate in a brief survey to share your thoughts and insights on the Oncology Case Discussion Forum initiative. Your feedback will help us refine the platform and ensure its success. https://lnkd.in/dPS-892g Please find attached document outlining the proposal in more detail. Thank you in advance for your time and contribution. Together, we can create a valuable resource that will benefit the entire oncology community. Should you have any questions or require further information, please feel free to reach out to me directly. Best regards, Dr. Saba Karim
To view or add a comment, sign in
-
In this interview, Barry Russo, MBA, discussed his session title "Defining Value in ONcology: Executing VBC Accurately & Ethically to Account for All Stakeholders," at the 2024 Community Oncology Conference. "The most important part of the care process—when working with a patient in a value-based environment—is recognizing that we have to manage the whole person," said Mr Russo. Click the link to access the interview: https://lnkd.in/e9RPzWwj #JournalofClinicalPathways #JCP #ValuedBasedCare #VBC #CommunityOncologyConference #valuebasedcaremodels
It Takes a Village: Managing the Needs of All Stakeholders in Value-Based Care Models
hmpgloballearningnetwork.com
To view or add a comment, sign in
-
Oncology clinical trials are rife with scientific, operational and emotional hurdles. Specialized #oncology teams offer several key advantages to sponsors looking to shorten timelines for sophisticated therapies. See the criteria that guides successful CRO selection. https://hubs.ly/Q02qbRv90 #clinicaltrials #clinicalresearch #cancerresearch
Why Select a Specialized Oncology CRO?
https://www.precisionformedicine.com
To view or add a comment, sign in
-
We are excited to share the latest findings from our ASCO 2024 Post-Conference Survey! Dive into the detailed analysis of oncologists' perspectives on the most groundbreaking presentations and the future of cancer treatment. Explore the emerging trends, innovative therapies, and impactful discussions that are shaping the oncology landscape. 🔗 Read the full blog here: https://bit.ly/3LcNHNQ #ASCO2024 #Oncology #CancerResearch #MedicalConference #HealthInsights #ZoomRx #CancerTreatment #HealthcareInnovation #MedicalSurvey #OncologyUpdates
ASCO 2024: What the Post-conference Survey Reveals
blog.zoomrx.com
To view or add a comment, sign in
-
Check out this webinar if you are in the #oncology space
If you are passionate about staying up-to-date with the latest developments in oncology research, you cannot miss this event. The session will cover strategies for accelerating the introduction of innovative cancer treatments for patients based on the FDA's Project FrontRunner initiative. Esteemed speakers, including Robin Bliss, Ph.D., John Kirk, ScD, and Patricia Rodriguez, will share their extensive knowledge on advanced trial designs, navigating patient safety in unexplored areas, and maximizing the benefits of early therapeutic interventions. Don’t miss this opportunity to advance your oncology research and development knowledge. Register now and be part of the change 👇 https://bit.ly/3TBODjR #OncologyInnovation #ProjectFrontRunner
Webinar: Advancing Development of New Oncology Therapies: Aligning with FDA’s Project FrontRunner
veristat.com
To view or add a comment, sign in
78,744 followers